PTC
WGS icon

Private Trust Company’s GeneDx Holdings WGS Stock Holding History

Private Trust Company’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-61
Closed -$3.92K – 2809
2026
Q1 		$3.92K Hold
61
– – ﹤0.01% 2252
2025
Q4 		$7.93K Sell
61
-85
-58% -$11.7K ﹤0.01% 2020
2025
Q3 		$15.7K Sell
146
-110
-43% -$12K ﹤0.01% 1736
2025
Q2 		$23.6K Buy
256
+65
+34% +$5.1K ﹤0.01% 1507
2025
Q1 		$16.9K Buy
191
+19
+11% +$1.65K ﹤0.01% 1627
2024
Q4 		$13.2K Buy
172
+113
+192% +$7.89K ﹤0.01% 1654
2024
Q3 		$2.5K Buy
+59
New +$1.99K ﹤0.01% 2129

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Private Trust Company's WGS Position: Q2 2026 in Review

Private Trust Company sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 61 shares — an estimated $3.92K sold.

Private Trust Company first reported a position in WGS in Q3 2024 and held it in 7 quarters. The position peaked at $23.6K in Q2 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Private Trust Company reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • Private Trust Company sold 61 GeneDx Holdings shares in Q2 2026, an estimated $3.92K.
  • Private Trust Company first reported a position in GeneDx Holdings in Q3 2024 and held it in 7 quarters.
  • Private Trust Company's GeneDx Holdings position peaked at $23.6K in Q2 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.